# The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents

> **NCT02973061** · — · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Growth Hormone Deficiency
- Attention Deficit Disorder
- Idiopathic Short Stature

## Interventions

- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT02973061
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973061, "The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT02973061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*